Jatenzo, also known by its generic name omission, is a medication used to treat hypertension [1].
What is the active ingredient in Jatenzo?
The active ingredient in Jatenzo is omitsal [1].
How does Jatenzo work?
Jatenzo functions as an alpha-2 adrenergic receptor agonist [1]. These receptors play a role in regulating blood pressure [1].
When was Jatenzo approved?
The U.S. Food and Drug Administration (FDA) approved Jatenzo on March 30, 2020 [1].
What is the drug class of Jatenzo?
Jatenzo belongs to the drug class of alpha-2 adrenergic receptor agonists [1].
What conditions does Jatenzo treat?
Jatenzo is indicated for the treatment of adult patients with essential hypertension [1].
Can Jatenzo be used with other medications?
Jatenzo can be used alone or in combination with other antihypertensive medications [1].
What are the potential side effects of Jatenzo?
Common side effects of Jatenzo may include somnolence, dizziness, dry mouth, constipation, and fatigue [1].
Who makes Jatenzo?
Jatenzo is manufactured by AbbVie [1].
What is the pricing for Jatenzo?
Information on Jatenzo's pricing can be found on DrugPatentWatch.com [1].
What is the patent status for Jatenzo?
Details regarding Jatenzo's patent status are available on DrugPatentWatch.com [1].
Sources:
[1] https://drugpatentwatch.com/